Search

James Henry Alstrum Acevedo

Supervisory Patent Examiner (ID: 1021, Phone: (571)272-5548 , Office: P/1675 )

Most Active Art Unit
1616
Art Unit(s)
1622, 1616, 1654, 1675
Total Applications
708
Issued Applications
222
Pending Applications
98
Abandoned Applications
392

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19656913 [patent_doc_number] => 20240423978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL LUNG CANCER [patent_app_type] => utility [patent_app_number] => 18/635697 [patent_app_country] => US [patent_app_date] => 2024-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18635697 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/635697
EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL LUNG CANCER Apr 14, 2024 Abandoned
Array ( [id] => 19231395 [patent_doc_number] => 20240188585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/585703 [patent_app_country] => US [patent_app_date] => 2024-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585703 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/585703
METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION Feb 22, 2024 Pending
Array ( [id] => 19231395 [patent_doc_number] => 20240188585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/585703 [patent_app_country] => US [patent_app_date] => 2024-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585703 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/585703
METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION Feb 22, 2024 Pending
Array ( [id] => 20401185 [patent_doc_number] => 12491144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Toothpaste composition [patent_app_type] => utility [patent_app_number] => 18/128025 [patent_app_country] => US [patent_app_date] => 2023-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7857 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128025 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/128025
Toothpaste composition Mar 28, 2023 Issued
Array ( [id] => 19477498 [patent_doc_number] => 20240325540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => METHOD OF ENHANCING HUMAN IMMUNITY THROUGH SOLID WATER PARTICLES [patent_app_type] => utility [patent_app_number] => 18/126672 [patent_app_country] => US [patent_app_date] => 2023-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18126672 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/126672
METHOD OF ENHANCING HUMAN IMMUNITY THROUGH SOLID WATER PARTICLES Mar 26, 2023 Pending
Array ( [id] => 20371176 [patent_doc_number] => 12478590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => In situ method of making porous 2D based tri-nanocomposite for use in medical treatment [patent_app_type] => utility [patent_app_number] => 18/085433 [patent_app_country] => US [patent_app_date] => 2022-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 0 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085433 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/085433
In situ method of making porous 2D based tri-nanocomposite for use in medical treatment Dec 19, 2022 Issued
Array ( [id] => 20371176 [patent_doc_number] => 12478590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => In situ method of making porous 2D based tri-nanocomposite for use in medical treatment [patent_app_type] => utility [patent_app_number] => 18/085433 [patent_app_country] => US [patent_app_date] => 2022-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 0 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085433 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/085433
In situ method of making porous 2D based tri-nanocomposite for use in medical treatment Dec 19, 2022 Issued
Array ( [id] => 17595779 [patent_doc_number] => 20220145353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => Sensitive glucose assay [patent_app_type] => utility [patent_app_number] => 17/348748 [patent_app_country] => US [patent_app_date] => 2021-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348748 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/348748
Sensitive glucose assay Jun 14, 2021 Abandoned
Array ( [id] => 18468816 [patent_doc_number] => 20230203098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/801261 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/801261
HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE Feb 21, 2021 Pending
Array ( [id] => 18468816 [patent_doc_number] => 20230203098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/801261 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/801261
HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE Feb 21, 2021 Pending
Array ( [id] => 17595697 [patent_doc_number] => 20220145271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => Enzyme with acyl transfer function and application thereof [patent_app_type] => utility [patent_app_number] => 17/432099 [patent_app_country] => US [patent_app_date] => 2020-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432099 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/432099
Enzyme with acyl transfer function and application thereof Dec 6, 2020 Issued
Array ( [id] => 19002036 [patent_doc_number] => 20240066107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => PHARMACEUTICAL COMPOSITION AND KIT FOR TREATING GOUT [patent_app_type] => utility [patent_app_number] => 16/996846 [patent_app_country] => US [patent_app_date] => 2020-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996846 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/996846
Pharmaceutical composition and kit for treating gout Aug 17, 2020 Issued
Array ( [id] => 18211323 [patent_doc_number] => 20230057586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => OPTIMIZED CULTURE MEDIA FOR CLOSTRIDIA BACTERIA [patent_app_type] => utility [patent_app_number] => 17/633996 [patent_app_country] => US [patent_app_date] => 2020-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633996 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/633996
OPTIMIZED CULTURE MEDIA FOR CLOSTRIDIA BACTERIA Jul 20, 2020 Abandoned
Array ( [id] => 17990462 [patent_doc_number] => 20220356499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => ENDOGLUCANASE, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/621992 [patent_app_country] => US [patent_app_date] => 2020-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4666 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621992 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/621992
ENDOGLUCANASE, AND USE THEREOF Jul 19, 2020 Abandoned
Array ( [id] => 19326192 [patent_doc_number] => 12043859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-23 [patent_title] => Recovery, decarboxylation, and purification of cannabinoids from engineered cell cultures [patent_app_type] => utility [patent_app_number] => 17/426973 [patent_app_country] => US [patent_app_date] => 2020-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13207 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426973 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/426973
Recovery, decarboxylation, and purification of cannabinoids from engineered cell cultures Jan 29, 2020 Issued
Array ( [id] => 17685913 [patent_doc_number] => 20220193205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => METHODS OF TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/420296 [patent_app_country] => US [patent_app_date] => 2020-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420296 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/420296
METHODS OF TREATING CANCER Jan 6, 2020 Abandoned
Array ( [id] => 17383964 [patent_doc_number] => 20220031816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 17/299682 [patent_app_country] => US [patent_app_date] => 2019-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299682 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/299682
CANCER TREATMENT Dec 5, 2019 Abandoned
Array ( [id] => 15927843 [patent_doc_number] => 20200155555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => VITAMIN RECEPTOR DRUG DELIVERY CONJUGATES FOR TREATING INFLAMMATION [patent_app_type] => utility [patent_app_number] => 16/682200 [patent_app_country] => US [patent_app_date] => 2019-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33897 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16682200 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/682200
VITAMIN RECEPTOR DRUG DELIVERY CONJUGATES FOR TREATING INFLAMMATION Nov 12, 2019 Abandoned
Array ( [id] => 17343648 [patent_doc_number] => 20220009979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT DYSREGULATION USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/267308 [patent_app_country] => US [patent_app_date] => 2019-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267308 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/267308
FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT DYSREGULATION USING THE SAME Aug 21, 2019 Abandoned
Array ( [id] => 17038248 [patent_doc_number] => 20210255207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => BIOMARKERS FOR COLORECTAL CANCER [patent_app_type] => utility [patent_app_number] => 17/056066 [patent_app_country] => US [patent_app_date] => 2019-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/056066
BIOMARKERS FOR COLORECTAL CANCER May 22, 2019 Abandoned
Menu